Lv4
420 积分 2022-03-21 加入
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
10小时前
已完结
Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD
13小时前
已完结
Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis
13小时前
已完结
With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?
17小时前
已完结
P045 Effect of Etrasimod on Circulating Lymphocyte Subsets: Data From a Randomized Phase 1 Study in Healthy Japanese and Caucasian Men
18小时前
已完结
Etrasimod for the Treatment of Ulcerative Colitis
20小时前
已完结
Therapeutic drug monitoring in inflammatory bowel disease: recent developments
3天前
已完结
Global prevalence of biologic drugs use in inflammatory bowel diseases: a systematic review and meta-analysis
5天前
已完结
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
7天前
已完结
The role of bacteriophage in inflammatory bowel disease and its therapeutic potential
11天前
已完结
皖公网安备34019202002308
